Aryeh Jason 4

What Happened

• Aryeh Jason, a director of Orchestra BioMed Holdings, purchased 8,971 shares on May 15, 2026 in an open-market/private purchase (reported as a purchase, code P). The filing shows a weighted-average price of $3.90 per share for a total reported value of $34,987.
• The purchase was executed in multiple transactions at prices ranging from $3.70 to $4.03 (per footnote). Purchases are generally viewed as more informative than routine sales, but this report is factual only — no inference about motivation.

Key Details

• Transaction date: 2026-05-15; Filing date: 2026-05-19 (filed within the two-business-day Form 4 window).
• Price: Weighted average $3.90; range $3.70–$4.03 across multiple trades (see footnote).
• Shares acquired: 8,971; total reported value: $34,987.
• Shares owned after transaction: Not specified in the provided summary (check the full Form 4 for post-transaction holdings).
• Footnote: Reporting person will provide, upon request, full breakdown of how many shares were bought at each price within the reported range.

Context

• This was an open-market purchase (buy), not an option exercise, gift, or award. Open-market buys by insiders can signal confidence but should be considered alongside other information (company fundamentals, timing, and size of the purchase).
• Filing appears timely under SEC rules (filed within two business days).